Human Milk Oligosaccharides (HMO) Market Growth Trend & Forecast with latest research study released by Delvens evaluating the market risk side analysis, highlighting opportunities, and leveraging strategic and tactical decision-making support. The report provides information on market trends and development, growth drivers, technologies, and the changing investment structure of the Global market.
The global Human Milk Oligosaccharides (HMO) Market size is projected to reach a CAGR of 23.4% to Forecast 2030.
Get Free Sample Report: https://www.delvens.com/get-free-sample/human-milk-oligosaccharides-hmo-market
Human milk oligosaccharides, also known as human milk glycans, are short polymers of simple sugars that can be found in high concentrations exclusively in human breast milk. Human milk oligosaccharides promote the development of the immune system, can reduce pathogen infections, and improve brain development and cognition. Approximately 200 structurally different human milk oligosaccharides are known and the exact composting of these varies from mother to mother.
The functional benefits of these products have created a huge demand for the biosynthetic production of HMOs for use as additives in infant formulas and other dietary products. HMO molecules can be produced chemically, through fermentation, or through enzymatic synthesis. Moreover, the surge in demand for HMOs has increased the utilization of various nutritional products used as food or dietary supplements.
Key Findings
· The type segment is further segmented into 2’ FL, 3’ FL, 3’ SL, and 6’ SL. The 2’FL segment garnered the highest market share in 2022, as 2'-fucosyllactose (2’FL) is well-known for its ability to protect against infectious diseases by preventing toxins and pathogens from adhering to epithelial cells.
· Human milk oligosaccharides, also known as human milk glycans, are short polymers of simple sugars that can be found in high concentrations exclusively in human breast milk.
· Asia Pacific consisting of countries like China, India, Japan, Australia & New Zealand, and Others is found to dominate the HMO market with the presence of a large consumer base for HMO derivative products.
Competitive Landscape:
· Abbott Laboratories
· BASF S.E.
· Biosynth Carbosynth
· Chr. Hansen Holding A/S
· Dextra Laboratories Ltd.
· Dupont Nutrition & Biosciences
· Elicityl S.A.
· Glycom A/S
· Glycosyn
· Inbiose NV
· Medolac Laboratories
· Neolacta Lifesciences Pvt. Ltd
· Nestle Health Science
· Royal DSM
· ZuChem
For More Inquiry Contact us: https://www.delvens.com/Inquire-before-buying/human-milk-oligosaccharides-hmo-market
The Report helps to identify the opportunities in Global Regions:
· North America (the United States, Canada, and Mexico)
· Europe (Germany, UK, France, Italy, Russia, Turkey, etc.)
· Asia-Pacific (China, Japan, Korea, India, Australia, and Southeast Asia (Indonesia, Thailand, Philippines, Malaysia, and Vietnam))
· South America (Brazil etc.)
· The Middle East and Africa (North Africa and GCC Countries)
Recent Developments
In August 2021, nestle launched the new NAN SUPREME PRO 3 formula products with five human milk oligosaccharides (2’-FL, DFL, LNT, 3’-SL, and 6’-SL), which it claims enhance children’s immunity systems.
In September 2020, Chr. Hansen acquired Jennewein Biotechnologies GmbH and a strong patent portfolio relating to the production of human milk oligosaccharides (HMOs) and several litigations related hereto.
Reasons to Acquire
· Increase your understanding of the market for identifying the best and suitable strategies and decisions on the basis of sales or revenue fluctuations in terms of volume and value, distribution chain analysis, market trends and factors.
· Gain authentic and granular data access for Human Milk Oligosaccharides (HMO) Market so as to understand the trends and the factors involved behind changing market situations.
· Qualitative and quantitative data utilization to discover arrays of future growth from the market trends of leaders to market visionaries and then recognize the significant areas to compete in the future.
· In-depth analysis of the changing trends of the market by visualizing the historic and forecast year growth patterns.
Access Full Report: https://www.delvens.com/report/human-milk-oligosaccharides-hmo-market
In addition to the market data for Human Milk Oligosaccharides (HMO) Market, Delvens offers client-centric reports customized according to the company’s specific demand and requirement.
More Reports From Delvens:
About Us:
Delvens is a strategic advisory and consulting company headquartered in New Delhi, India. The company holds expertise in providing syndicated research reports, customized research reports and consulting services. Delvens qualitative and quantitative data is highly utilized by each level from niche to major markets, serving more than 1K prominent companies by assuring to provide the information on country, regional and global business environment. We have a database for more than 45 industries in more than 115+ major countries globally.
Delvens database assists the clients by providing in-depth information in crucial business decisions. Delvens offers significant facts and figures across various industries namely Healthcare, IT & Telecom, Chemicals & Materials, Semiconductor & Electronics, Energy, Pharmaceutical, Consumer Goods & Services, Food & Beverages. Our company provides an exhaustive and comprehensive understanding of the business environment.
Contact us:
Unit No. 01, 3rd Floor, Plot No. 56, Block B
Sector 2 Noida, Near Noida Sector 15 Metro Station 201301, IN
+44 20 3290 6466
+0120- 4903958
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek